ESR1 and breast carcinoma: It has been highlighted that, in addition to their potent cytotoxic effects against breast cancer cell lines, coumarins of different chemical backgrounds have exhibited strong estrogen receptor alpha antagonistic effects, making them suitable candidates for developing anticancer agents with multiple sites of action [47,48,49,50].